Cialis Super Active: Uses, dosage, side effects, warnings & patient reviews

What is Cialis Super Active?

Cialis Super Active is marketed as a tadalafil softgel product. Tadalafil is a selective phosphodiesterase type 5 (PDE5) inhibitor that increases cyclic guanosine monophosphate (cGMP) signaling in the corpus cavernosum and can facilitate an erection in response to sexual stimulation.

The active ingredient tadalafil is available in FDA-approved tablet formulations under products such as Cialis. However, a softgel product sold under the name Cialis Super Active should not automatically be treated as equivalent in dose consistency, absorption profile, storage stability, or manufacturing quality.

Patients seeking treatment for erectile dysfunction should consult a licensed healthcare provider for proper evaluation and, if appropriate, use a regulated tadalafil product dispensed by a licensed pharmacy. A broader list of treatments is available in the erectile dysfunction drug category.

How to Take Cialis Super Active

The information below is based on FDA-approved tadalafil tablets and is provided as reference context. Softgel products sold under the name Cialis Super Active should not be self-dosed as if they were verified equivalents of approved tadalafil tablets.

As-Needed Dosing (Reference: FDA-Approved Tadalafil Tablets)

The recommended starting dose of approved tadalafil for use as needed is 10 mg, taken before anticipated sexual activity. The dose may be increased to 20 mg or decreased to 5 mg based on efficacy and tolerability. The maximum recommended dosing frequency is once per day.

Once-Daily Dosing (Reference: FDA-Approved Tadalafil Tablets)

The recommended starting dose for once-daily use for erectile dysfunction is 2.5 mg, taken at approximately the same time every day. The dose may be increased to 5 mg based on efficacy and tolerability. For benign prostatic hyperplasia (BPH) or ED/BPH, the approved once-daily dose is 5 mg.

Important Administration Notes

• Tadalafil may be taken with or without food.
• Do not take more than one dose within a 24-hour period unless specifically using a clinician-directed once-daily regimen.
• Sexual stimulation is required for tadalafil to facilitate an erection.

For practical guidance on getting the best results from approved tadalafil, see this detailed guide.

Side Effects of Cialis Super Active

The adverse reactions below are based on clinical and labeling data for tadalafil. For a broader clinical explanation of what is common and what is not, see this guide to ED pill side effects.

Common Side Effects

• Headache
• Dyspepsia (indigestion)
• Back pain
• Myalgia (muscle pain)
• Nasal congestion
• Flushing
• Pain in limb

Back pain and myalgia are usually mild to moderate and often resolve within 48 hours.

Less Common Side Effects

• Dizziness
• Upper abdominal pain
• Prolonged erections

Serious Side Effects (Seek Immediate Medical Attention)

• Priapism: An erection lasting more than 4 hours
• Sudden vision loss: Cases of non-arteritic anterior ischemic optic neuropathy (NAION) have been reported with PDE5 inhibitors
• Sudden hearing loss: Sudden decrease or loss of hearing has been reported in postmarketing experience
• Severe hypotension or fainting: especially with interacting drugs or substantial alcohol intake
• Severe allergic reaction: Rash, hives, swelling, or difficulty breathing

What is Cialis Super Active Used For?

Cialis Super Active is commonly marketed online as a treatment for erectile dysfunction. This should not be confused with the FDA-reviewed indications established for approved tadalafil tablets.

FDA-Approved Uses of Tadalafil Tablets

• Treatment of erectile dysfunction (ED)
• Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH)
• Treatment of ED and the signs and symptoms of BPH (ED/BPH)

Important Clarification

These approved uses apply to regulated tadalafil tablets, not to softgel products sold under names such as Cialis Super Active.

For broader navigation within this treatment area, see the full list of erectile dysfunction medications.

Important Safety Concerns and Considerations

Regulatory Status and Product Reliability

Cialis Super Active is a non-FDA-approved tadalafil softgel product. Even if it is advertised as containing tadalafil, there is no FDA verification that the stated dose, formulation performance, impurity profile, or manufacturing quality matches approved tadalafil tablets. Products sold through unregulated sources may contain the wrong dose, undeclared ingredients, or contaminants.

Cardiovascular Risk

Sexual activity places additional demand on the cardiovascular system. Tadalafil also causes vasodilation and can lower blood pressure. Men with unstable cardiovascular disease, recent myocardial infarction, recent stroke, unstable angina, severe heart failure, marked hypotension, or uncontrolled hypertension require formal medical assessment before using a PDE5 inhibitor.

Priapism

Priapism, an erection lasting more than 4 hours, is a rare but serious adverse event. Without prompt treatment, permanent erectile tissue damage can occur.

Sudden Sensory Loss

Rare postmarketing reports describe sudden decrease or loss of vision and sudden decrease or loss of hearing in patients taking PDE5 inhibitors. Any abrupt visual or auditory change requires immediate medical attention.

Critical Warnings for Cialis Super Active Use

Absolute Contraindication: Nitrates and Guanylate Cyclase Stimulators

Patients taking any form of organic nitrate or nitric oxide donor must not take tadalafil. The same applies to guanylate cyclase stimulators such as riociguat. These combinations can cause a severe, potentially life-threatening drop in blood pressure. For background on nitrate medicines, see nitroglycerin prescribing information.

Concomitant Use with Alpha-Blockers

Alpha-blockers can lower blood pressure. When combined with tadalafil, there is a risk of symptomatic hypotension. In patients using tadalafil for ED, the patient should be stable on alpha-blocker therapy before tadalafil is started, and tadalafil should begin at the lowest recommended dose. Tadalafil is not recommended in combination with alpha-blockers for the treatment of BPH.

Cardiovascular Status Assessment

Before prescribing a PDE5 inhibitor, clinicians should determine whether sexual activity is medically appropriate for the patient’s cardiovascular status.

Grapefruit and Strong CYP3A4 Inhibitors

Grapefruit juice and strong CYP3A4 inhibitors may increase tadalafil exposure and raise the risk of adverse effects.

Unregulated Product Risk

Products sold through unregulated channels should not be assumed to contain the stated ingredient or the stated dose, even if the packaging resembles a known brand.

Reference Dosage for FDA-Approved Tadalafil Tablets

The information below reflects FDA-approved tadalafil tablets and is provided only as reference context.

FDA-Approved Tadalafil Dosage for Erectile Dysfunction and BPH

Dosage Adjustments for Specific Populations

• Renal impairment, as-needed ED dosing: If creatinine clearance is 30-50 mL/min, start at 5 mg not more than once per day; maximum 10 mg every 48 hours. If creatinine clearance is less than 30 mL/min or the patient is on hemodialysis, maximum dose is 5 mg every 72 hours.
• Renal impairment, once-daily use: Once-daily use is not recommended when creatinine clearance is less than 30 mL/min or in hemodialysis.
• Hepatic impairment: In mild to moderate impairment, as-needed dosing should not exceed 10 mg once per day. Severe hepatic impairment is a situation where use is generally not recommended.
• Strong CYP3A4 inhibitors: Dose reduction may be necessary. For as-needed use, do not exceed 10 mg every 72 hours; for once-daily use, dose should not exceed 2.5 mg.

Important Considerations

• Do not exceed the recommended dose or frequency.
• Sexual stimulation is required for tadalafil to facilitate an erection.
• This section should not be used to self-dose a softgel product of uncertain equivalence.

Drug Interactions with Tadalafil

Tadalafil has clinically significant drug interactions. Patients should provide a complete medication list before use.

Additional Information

Storage and Handling

Because softgel products sold under this name do not have a standardized regulator-reviewed product profile, storage expectations may be less reliable than for approved tadalafil tablets. For approved tadalafil tablets, room-temperature storage in a dry place is recommended. Keep all medications out of reach of children.

Obtaining Tadalafil Safely

Patients requiring treatment for erectile dysfunction should consult a licensed healthcare provider and obtain FDA-approved tadalafil through a licensed pharmacy. Avoid websites that sell prescription ED products without a prescription. For general safe-purchasing guidance, refer to this guide.

Reporting Adverse Events

Patients experiencing side effects should report them to their healthcare provider and, when appropriate, to the FDA MedWatch program.

References and Medical Sources

The information on this page is compiled from FDA-approved tadalafil labeling, FDA safety communications, and peer-reviewed clinical literature.

1. DailyMed. Tadalafil tablets. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=351e28ca-3ae6-e535-e063-6394a90a9fb7&version=3
2. U.S. Food and Drug Administration (FDA). Sexual Enhancement and Energy Product Notifications. https://www.fda.gov/drugs/medication-health-fraud-notifications/sexual-enhancement-and-energy-product-notifications
3. Young JM, Feldman RA, Auerbach SM, et al. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial. J Androl. 2005;26(3):310-318. DOI: 10.2164/jandrol.04126
4. Kloner RA, Jackson G, Emmick JT, et al. Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men. J Urol. 2004;172(5 Pt 1):1935-1940. DOI: 10.1097/01.ju.0000142687.75577.e4
5. MedlinePlus. Tadalafil. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a604008.html

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.